1 Wildgruber M, Swirski FK, Zernecke A. Molecular

imaging of inf lammation in atherosclerosis[J].

Theranostics, 2013, 3:865-884.

2 Hayden MR, Tyagi SC. Uric acid:A new look at an

old risk marker for cardiovascular disease, metabolic

syndrome, and type 2 diabetes mellitus:The urate

redox shuttle[J]. Nutr Metab (Lond), 2004, 1:10.

3 Lee YM, Bae SG, Lee SH, et al. Persistent organic

pollutants and hyperuricemia in the U.S. general

population[J]. Atherosclerosis, 2013, 230:1-5.

4 Patetsios P, Song M, Shutze WP, et al. Identification

of uric acid and xanthine oxidase in atherosclerotic

plaque[J]. Am J Cardiol, 2001, 88:188-191, A6.

5 中华医学会内分泌学会. 高尿酸血症和痛风治疗的中

国专家共识[J]. 中华内分泌代谢杂志, 2013, 29:913-

920.

6 Kanellis J, Feig DI, Johnson RJ. Does asymptomatic

hyperuricaemia contribute to the development of

renal and cardiovascular disease? An old controversy

renewed[J]. Nephrology (Carlton), 2004, 9:394-399.

7 Hermus L, Lefrandt JD, Tio RA, et al. Carotid plaque

formation and serum biomarkers[J]. Atherosclerosis,

2010, 213:21-29.

8 Nakagawa T, Mazzali M, Kang DH, et al. Hyperuricemia

causes glomerular hypertrophy in the rat[J]. Am J

Nephrol, 2003, 23:2-7.

9 Kang DH, Han L, Ouyang X, et al. Uric acid causes

vascular smooth muscle cell proliferation by entering

cells via a functional urate transporter[J]. Am J

Nephrol, 2005, 25:425-433.

10 Kang DH, Park SK, Lee IK, et al. Uric acid-induced C-reactive protein expression:implication on cell

proliferation and nitric oxide production of human

vascular cells[J]. J Am Soc Nephrol, 2005, 16:3553-

3562.

11 Nishi K, Itabe H, Uno M, et al. Oxidized LDL in

carotid plaques and plasma associates with plaque

instability[J]. Arterioscler Thromb Vasc Biol, 2002,

22:1649-1654.

12 Mathiesen EB, Bonaa KH, Joakimsen O. Low levels

of high-density lipoprotein cholesterol are associated

with echolucent carotid artery plaques:the tromso

study[J]. Stroke, 2001, 32:1960-1965.

13 Schlotte V, Sevanian A, Hochstein P, et al. Effect

of uric acid and chemical analogues on oxidation of

human low density lipoprotein in vitro[J]. Free Radic

Biol Med, 1998, 25:839-847.

14 Yur'Eva EA, Sukhorukov VS, Murashov AN, et al.

Biochemical indicators of atherogenic and protective

activity of xydiphone in experimental animals[J]. Bull

Exp Biol Med, 2012, 153:459-462.

15 Kanellis J, Watanabe S, Li JH, et al. Uric acid

stimulates monocyte chemoattractant protein-1

production in vascular smooth muscle cells via

mitogen-activated protein kinase and cyclooxygenase-

2[J]. 2003, 41:1287-1293.

16 Netea MG, Kullberg BJ, Blok WL, et al. The role of

hyperuricemia in the increased cytokine production

after lipopolysaccharide challenge in neutrophnic

mice[J]. Blood, 1997, 89:577-582.

17 Ehara S, Kobayashi Y, Yoshiyama M, et al. Spotty

calcification typifies the culprit plaque in patients

with acute myocardial infarction:an intravascular

ultrasound study[J]. Circulation, 2004, 110:3424-3429.

18 Vengreny uk Y, Carlier S, Xanthos S, et al. A

hypothesis for vulnerable plaque rupture due to stressinduced

debonding around cellular microcalcifications

in thin fibrous caps[J]. Proc Natl Acad Sci U S A,

2006, 103:14678-14683.

19 Bost rom K, Wat son KE, Hor n S, et al. Bone

mor phogenet ic prot ei n expr e s sion i n human

atherosclerotic lesions[J]. J Clin Invest, 1993, 91:1800-

1809.

20 O'Br ien ER, Ga r vi n MR, St ewa r t DK, e t a l.

Osteopontin is synthesized by macrophage, smooth

muscle, and endothelial cells in pr ima r y and

restenotic human coronary atherosclerotic plaques[J].

Arterioscler Thromb, 1994, 14:1648-1656.

21 K h o s l a UM, Z h a r i k o v S , Fi n c h J L , e t a l .

Hyperuricemia induces endothelial dysfunction[J].

Kidney Int, 2005, 67:1739-1742.

22 张雪光, 洪权, 侯凯, 等. 高尿酸通过miR-155下调

eNOS表达而导致内皮细胞功能障碍[J]. 南方医科大

学学报, 2013, 33:1141-1145.

23 Ginsberg MH, Kozin F, O'Malley M, et al. Release of

platelet constituents by monosodium urate crystals[J].

J Clin Invest, 1977, 60:999-1007.

24 Hink HU, Santanam N, Dikalov S, et al. Peroxidase

properties of extracellular superoxide dismutase:role

of ur ic acid in modulating in vivo activity[J].

Arterioscler Thromb Vasc Biol, 2002, 22:1402-1408.

25 Neogi T, Ellison RC, Hunt S, et al. Serum uric acid

is associated with carotid plaques:the National Heart,

Lung, and Blood Institute Family Heart Study[J]. J

Rheumatol, 2009, 36:378-384.

26 Ishizaka N, Ishizaka Y, Toda E, et al. Association

between serum uric acid, metabolic syndrome, and

carotid atherosclerosis in Japanese individuals[J].

Arterioscler Thromb Vasc Biol, 2005, 25:1038-1044.

27 李岩, 赵冬, 刘静, 等. 高尿酸血症与新发颈动脉粥样

硬化斑块的关系[J]. 中华内科杂志, 2008, 47:906-909.

28 Li Q, Yang Z, Lu B, et al. Serum uric acid level and

its association with metabolic syndrome and carotid

atherosclerosis in patients with type 2 diabetes[J].

Cardiovasc Diabetol, 2011, 10:72.

29 Fukui M, Tanaka M, Shiraishi E, et al. Serum

uric acid is associated with microalbuminuria and

subclinical atherosclerosis in men with type 2 diabetes

mellitus[J]. Metabolism, 2008, 57:625-629.

30 Oikonen M, Wendelin-Saarenhovi M, Lyytikainen

LP, et al. Associations between serum uric acid and

markers of subclinical atherosclerosis in young adults.

The cardiovascular risk in Young Finns study[J].

Atherosclerosis, 2012, 223:497-503.

31 Cuspidi C, Valerio C, Sala C, et al. Lack of association

between serum uric acid and organ damage in a

never-treated essential hypertensive population at

low prevalence of hyperuricemia[J]. Am J Hypertens,

2007, 20:678-685.

32 Jalal DI, Jablonski KL, McFann K, et al. Vascular

endothelial function is not related to serum uric acid

in healthy adults[J]. Am J Hypertens, 2012, 25:407-

413.